Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-25-005992
Filing Date
2025-08-15
Accepted
2025-08-15 17:16:42
Documents
19
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A vnrx_10qa.htm   iXBRL 10-Q/A 92354
2 LEGAL OPINION OF STRADLING YOCCA CARLSON & RAUTH LLP. vnrx_51.htm EX-5.1 9139
3 AMENDMENT NO. 1 TO CAPITAL ON DEMAND SALES AGREEMENT vnrx_102.htm EX-10.2 18637
4 CERTIFICATION vnrx_313.htm EX-31.3 4281
5 CERTIFICATION vnrx_314.htm EX-31.4 4156
11 vnrx_ex51img1.jpg GRAPHIC 3444
  Complete submission text file 0001477932-25-005992.txt   294067

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20250630.xsd EX-101.SCH 5022
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20250630_lab.xml EX-101.LAB 19009
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20250630_cal.xml EX-101.CAL 898
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20250630_pre.xml EX-101.PRE 12183
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20250630_def.xml EX-101.DEF 2099
21 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10qa_htm.xml XML 5765
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36833 | Film No.: 251225646
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)